Stuart Lichtman

United States (US)
Past President

Biographical Info
Dr. Lichtman is an Attending Physician and Member, Memorial Hospital for Cancer and Allied Diseases, Member, Memorial Sloan-Kettering Cancer Center and Professor of Medicine, Weill Cornell Medical College. He is a member of the 65+ Clinical Geriatrics Program and Gynecologic Oncology Disease Management Team at the Center. He has been on the Board of Directors and Treasurer of SIOG since 2010 and has participated in multiple taskforces (Chemotherapy, as chair, Geriatric Assessment, Renal Dysfunction, Lymphoma, Oral Chemotherapy), US National Representative and Scientific Chair of the 2011 meeting. He has been a participant in the Alliance for Clinical Trials in Oncology (formerly CALGB) as a member of the Pharmacology and Experimental Therapeutics Committee (1990-2008), the Cancer in the Elderly Committee (1995-present). His work also included the Scientific Advisory Board of the Geriatric Oncology Consortium, the Elderly Taskforce of the Gynecologic Oncology Group, Cancer and Aging Research Group and the NCCN Guidelines Taskforce for the treatment, Evaluation of Older Women with Breast Cancer, Editorial Board of the Journal of Geriatric Oncology, External Advisory Board of the University of Iowa Cancer Center, Governing Board Cancer and the Kidney International Network. He has been a member of ASCO since 1988 and have been an active participant by serving on the Clinical Practice Committee, Scientific Program Committee, Geriatric Oncology Special Interest Group, an invited speaker at Educational Sessions, ASCO University, ASCO Post and a faculty member of the ASCO/AACR Vail Clinical Trials workshop for five sessions on the topic of special populations. He has been a guest editor for a special edition devoted to Geriatric Oncology for the Journal of Clinical Oncology (2007 and 2014). He has published over 100 articles in peer review journals, contributed to nine book chapters and edited three books and have been an invited speaker and many national and international meetings on Geriatric Oncology. In 2014 he received the ASCO BJ Kennedy Award for Scientific Excellence in Geriatric Oncology.